Sign in

CIK 0001907108

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
854012572
Phone
+1 212-547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$18,214
in 3 filings

Net −$18,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-11-18 See Tai Sandi Chief Development Officer Sale −386 $9.27 $4K 65,476
2025-10-17 See Tai Sandi Chief Development Officer Sale −3,844 $8.94 $34K 65,906
2025-10-17 See Tai Sandi Chief Development Officer Sale −44 $9.56 $421 65,862
2025-10-15 See Tai Sandi Chief Development Officer Grant or award +10,890 69,750
2025-08-18 See Tai Sandi Chief Development Officer Sale −382 $4.67 $2K 58,860
2025-05-16 See Tai Sandi Chief Development Officer Sale −367 $2.77 $1K 59,242
2025-03-14 See Tai Sandi Chief Development Officer Grant or award +5,720 $2.61 $15K 59,609
2025-02-19 See Tai Sandi Chief Development Officer Sale −1,486 $4.41 $7K 53,889
2025-01-07 See Tai Sandi Chief Development Officer Grant or award +38,750 55,375
2025-01-07 See Tai Sandi Chief Development Officer Grant or award · Stock Option (right to buy) +77,500 77,500

Page 1 of 1 · 10 trades